Mission Pharmacal

ProSolus Pharmaceuticals, owned by Mission Pharmacal, opened a new transdermal patch manufacturing facility in Boerne, Texas, more than doubling its capacity to up to 100 million patches per year. The company already has a facility in Miami, Florida.

ProSolus, a subsidiary of Mission Pharmacal, installed a second transdermal production facility at Mission's Boerne, Texas location, more than doubling total transdermal product output to over 100 million patches annually.